Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180282 · ClinicalTrials.gov registry record · NA
Impact of the M22-IPL Acne Filter on Acne Vulgaris
A NA study, sponsored by Lumenis Be.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02180282: Clinical Trial NA study, sponsored by Lumenis Be.
NCT02180282 is a NA study that was terminated before completion, run by Lumenis Be. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02180282, a NA study, was terminated before completion, sponsored by Lumenis Be.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count. .
Primary Outcome
The numbers of lesions are counted on each side of the face according to lesion type
Interventions
- DEVICE M22-IPL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT02180282 stopped before completion
NCT02180282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which M22-IPL is the first listed.
NCT02180282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02180282 about?
NCT02180282 is a clinical study titled "Impact of the M22-IPL Acne Filter on Acne Vulgaris". Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count. .
What is the current status of trial NCT02180282?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2014-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02180282?
The interventions under investigation include: M22-IPL (DEVICE).
Who is sponsoring clinical trial NCT02180282?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02180282's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia